United States:
Why Provider Regulations Still Matter To Evolving Health Care Delivery (Video Content)
13 October 2015
Foley & Lardner
To print this article, all you need is to be registered or login on Mondaq.com.
Experimentation and new ways of delivering care provide exciting
opportunities for health care providers. In this video, Foley
Partner Lawrence Vernaglia discusses why, in this age of
experimentation, it is critical for organizations to still be in
sync with provider regulations.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
POPULAR ARTICLES ON: Food, Drugs, Healthcare, Life Sciences from United States
FDA Ramps Up Actions On PFAS
Holland & Knight
The U.S. Food and Drug Administration (FDA) has increased regulatory activity with regard to per- and polyfluoroalkyl substances (PFAS).
Planning For The BIOSECURE Act
Foley Hoag LLP
Bipartisan legislation moving through the U.S. House and Senate, known as the BIOSECURE Act, could limit the ability of U.S. life sciences companies...
